{
  "company": {
    "name": "Amber Therapeutics (Bioinduction)",
    "website": "https://amber-tx.com/",
    "record": "https://startuphistory.org/c/amber-tx.com"
  },
  "status": null,
  "history_since": "2021-11-30T07:06:27.000Z",
  "baseline": {
    "snapshot_id": "2f849e1af4e051ac675871a5a8b5a8eb919d5981b66a436da3555237099e083f",
    "observed_at": "2021-11-30T07:06:27.000Z",
    "headline": "Amber TX | Developing Intelligent Bioelectrical Therapies",
    "description": "Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology",
    "evidence": "https://web.archive.org/web/20211130070627/https://www.amber-tx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-04T11:24:25.673Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2023-08-18T22:44:18.000Z",
      "variants": [
        {
          "headline": "Amber TX | Developing Intelligent Bioelectrical Therapies",
          "subhead": "Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology",
          "observed_at": "2021-11-30T07:06:27.000Z",
          "evidence": "https://web.archive.org/web/20211130070627/https://www.amber-tx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Amber TX | Developing Intelligent Bioelectrical Therapies",
          "subhead": "Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology",
          "observed_at": "2023-01-27T14:57:10.000Z",
          "evidence": "https://web.archive.org/web/20230127145710/https://www.amber-tx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Amber TX | Developing Intelligent Bioelectrical Therapies",
          "subhead": "Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology",
          "observed_at": "2023-08-18T22:44:18.000Z",
          "evidence": "https://web.archive.org/web/20230818224418/https://www.amber-tx.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Amber TX | Developing Intelligent Bioelectrical Therapies",
      "subhead": "Developing intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology",
      "from": "2021-11-30T07:06:27.000Z",
      "to": "2023-08-18T22:44:18.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20230818224418/https://www.amber-tx.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-11-30T07:06:27.000Z",
          "to": "2023-08-18T22:44:18.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-04T11:24:25.673Z",
      "variants": [
        {
          "headline": "Doing the extraordinary ‍ to restore the ordinary",
          "subhead": "Doing the extraordinary‍ to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.",
          "observed_at": "2024-06-11T09:24:12.000Z",
          "evidence": "https://web.archive.org/web/20240611092412/https://www.amber-tx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Doing the extraordinary ‍ to restore the ordinary",
          "subhead": "Doing the extraordinary‍ to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.",
          "observed_at": "2024-08-03T22:46:02.000Z",
          "evidence": "https://web.archive.org/web/20240803224602/https://www.amber-tx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Doing the extraordinary ‍ to restore the ordinary",
          "subhead": "Doing the extraordinary‍ to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.",
          "observed_at": "2025-01-08T18:36:15.000Z",
          "evidence": "https://web.archive.org/web/20250108183615/https://www.amber-tx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Doing the extraordinary ‍ to restore the ordinary",
          "subhead": "Doing the extraordinary‍ to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.",
          "observed_at": "2025-08-12T19:20:27.000Z",
          "evidence": "https://web.archive.org/web/20250812192027/https://www.amber-tx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Doing the extraordinary ‍ to restore the ordinary",
          "subhead": "Doing the extraordinary‍ to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.",
          "observed_at": "2026-01-07T23:50:06.000Z",
          "evidence": "https://web.archive.org/web/20260107235006/https://www.amber-tx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Doing the extraordinary ‍ to restore the ordinary",
          "subhead": "Doing the extraordinary‍ to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.",
          "observed_at": "2026-06-13T07:03:47.000Z",
          "evidence": "https://web.archive.org/web/20260613070347/https://www.amber-tx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Doing the extraordinary ‍ to restore the ordinary",
          "subhead": "Doing the extraordinary‍ to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.",
          "observed_at": "2026-11-04T11:24:25.673Z",
          "evidence": "https://www.amber-tx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Doing the extraordinary ‍ to restore the ordinary",
      "subhead": "Doing the extraordinary‍ to restore the ordinary. We’re developing the first adaptive neuromodulation therapy that is able to treat women suffering with mixed incontinence.",
      "from": "2024-06-11T09:24:12.000Z",
      "to": "2026-11-04T11:24:25.673Z",
      "captures": 7,
      "evidence": "https://www.amber-tx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2024-06-11T09:24:12.000Z",
          "to": "2026-11-04T11:24:25.673Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-ef980ba063802700bc1fe1444ee3bf453096f5647d90e22f7d6fe04de98a5151:baf6bb9468423224ae2c8696471e43d986b847c738e046efae630fe4c6fdebd6:compliance:a6a4cb773ccc68bf",
      "before_evidence": "https://web.archive.org/web/20230818224418/https://www.amber-tx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "compliance",
      "label": "Compliance",
      "summary": "Now states ISO 13485 compliance on its homepage.",
      "between": {
        "from": "2023-08-18T22:44:18.000Z",
        "to": "2024-06-11T09:24:12.000Z"
      },
      "evidence": "https://web.archive.org/web/20240611092412/https://www.amber-tx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-compliance"
    },
    {
      "n": 2,
      "id": "page-ef980ba063802700bc1fe1444ee3bf453096f5647d90e22f7d6fe04de98a5151:baf6bb9468423224ae2c8696471e43d986b847c738e046efae630fe4c6fdebd6:investors:328e6529aaddbfb2",
      "before_evidence": "https://web.archive.org/web/20230818224418/https://www.amber-tx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: Oxford Science, NEA, Lightsone, F Prime, Intuitive and 8VC.",
      "between": {
        "from": "2023-08-18T22:44:18.000Z",
        "to": "2024-06-11T09:24:12.000Z"
      },
      "evidence": "https://web.archive.org/web/20240611092412/https://www.amber-tx.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    }
  ],
  "update": {
    "headline": "Amber Therapeutics highlights ISO 13485 and investor logos",
    "summary": "Amber Therapeutics now states ISO 13485 compliance on its homepage and shows several investor logos, indicating emphasis on regulatory alignment and backing.",
    "points": [
      {
        "text": "Between August 2023 and June 2024, Amber Therapeutics updated its homepage to state ISO 13485 compliance.",
        "kind": "fact",
        "changes": [
          1
        ]
      },
      {
        "text": "Between August 2023 and June 2024, Amber Therapeutics began showing investor logos for Oxford Science, NEA, Lightsone, F Prime, Intuitive and 8VC.",
        "kind": "fact",
        "changes": [
          2
        ]
      },
      {
        "text": "The presence of ISO 13485 compliance language and multiple investor logos between August 2023 and June 2024 suggests a focus on highlighting regulatory credentials and investor support.",
        "kind": "interpretation",
        "changes": [
          1,
          2
        ]
      }
    ],
    "written_at": "2026-11-07T16:10:23.921Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Amber Therapeutics (Bioinduction)” company record, https://startuphistory.org/c/amber-tx.com"
}